AllNewsVideos'India On Astrazeneca' - 124 News Result(s)Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing RisksIndia News | Indo-Asian News Service | Thursday May 16, 2024 The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others. www.ndtv.comCovishield Side Effects: Doctors' Group Urges Centre To Review All Covid VaccinesIndia News | Press Trust of India | Friday May 10, 2024 In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine. www.ndtv.com"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety RowIndia News | Reported by Vishnu Som | Wednesday May 8, 2024 The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS. www.ndtv.com"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety RowIndia News | NDTV News Desk | Wednesday May 8, 2024 The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS. www.ndtv.comSupreme Court Agrees To Hear Plea Over Covishield Side-Effect ConcernIndia News | Reported by Ashish Bhargava | Monday May 6, 2024 The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield. www.ndtv.comNo Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca RowIndia News | NDTV Newsdesk | Thursday May 2, 2024 The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects. www.ndtv.comAstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In IndiaIndia News | Press Trust of India | Wednesday May 3, 2023 AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer. www.ndtv.comIndian Medical Experts Support Call For Covishield Vaccine Safety ReviewIndia News | Press Trust of India | Monday February 6, 2023 A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of the Oxford/AstraZeneca's COVID-19 vaccine, administered in India as Covishield. www.ndtv.comAstraZeneca India Gets Approval To Market Drug Treating Breast CancerIndia News | Press Trust of India | Friday August 19, 2022 Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer. www.ndtv.comLancet Study On Covishield Vaccine Protection Decline Is Misquoted: ExpertsIndia News | Asian News International | Thursday December 23, 2021 The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts. www.ndtv.comNext Virus Could Be More Lethal, Warns Oxford University Covid Vaccine CreatorWorld News | Press Trust of India | Monday December 6, 2021 The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious. www.ndtv.comCOVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: ReportWorld News | Press Trust of India | Friday August 27, 2021 A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday. www.ndtv.comClotting Linked With AstraZeneca Vaccine Very Rare, Says Oxford StudyWorld News | Press Trust of India | Thursday August 12, 2021 The very rare blood clots that can be caused by the Oxford/AstraZeneca coronavirus vaccine can be aggressive and deadly but is very rare, leading scientists have concluded in the findings of the first study of its kind on Thursday. www.ndtv.comCovishield Shot Should Be Accepted In Travel Schemes: UK's Boris JohnsonIndia News | Reuters | Friday July 2, 2021 British Prime Minister Boris Johnson on Friday said he saw no reason why people who received Indian-made AstraZeneca COVID-19 vaccines should be left out of vaccine passport schemes after the European Union did not initially recognise it. www.ndtv.comNo Ban On Covishield, Request Must For Approval Process: EU Envoy To IndiaIndia News | Asian News International | Tuesday June 29, 2021 European Union (EU) Ambassador to India Ugo Astuto has clarified there is no ban in the EU on the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University. www.ndtv.comMore News »'India On Astrazeneca' - 43 Video Result(s)Israel Takes Control Of Gaza Side Of Rafah Border, Indians Hesitate To Join Student Protests In US And MoreMay 8, 202423:55Supreme Court Agrees To Hear Plea Over Covishield Side-Effect ConcernMay 6, 20241:53"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-EffectMay 5, 20244:27"Information Is Not New, No Need To Worry": Ex WHO Chief Scientist On Covishield ConcernMay 5, 20244:56"All Drugs, Vaccines Come With Some Side-Effects": Top ExpertMay 5, 20241:07"No Vaccine Is 100% Effective Or 100% Safe": Expert On Covishield ConcernMay 5, 20242:18Ex WHO Chief Scientist, Top Doctors Answer AstraZeneca Vaccine ConcernsMay 5, 202426:44Astrazeneca's Big U-Turn, Admits Rare Blood Clot RiskApr 30, 20242:21Had Detailed Conversations On UK, India Vaccine App: UK Envoy To NDTVSep 22, 20211:33"Let In Jasprit Bumrah To Humiliate Us In Oval": UK Envoy To NDTVSep 22, 20210:43"Aim Is To Get India On List Of Countries That Don't Need Quarantine": UK EnvoySep 22, 202110:24On UK Vaccine Policy Row, Government Warns Of "Reciprocal Measures"Sep 21, 20212:36Different Booster Shots The Way Forward?Jun 23, 20217:15Indian Vaccine Export Ban Makes 91 Nations Vulnerable To New Strains: WHOJun 1, 20215:07Two Shots Of Covid Vaccines Effective Against Variant Found In India: UKMay 23, 20211:13More Videos »'India On Astrazeneca' - 124 News Result(s)Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing RisksIndia News | Indo-Asian News Service | Thursday May 16, 2024 The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others. www.ndtv.comCovishield Side Effects: Doctors' Group Urges Centre To Review All Covid VaccinesIndia News | Press Trust of India | Friday May 10, 2024 In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine. www.ndtv.com"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety RowIndia News | Reported by Vishnu Som | Wednesday May 8, 2024 The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS. www.ndtv.com"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety RowIndia News | NDTV News Desk | Wednesday May 8, 2024 The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS. www.ndtv.comSupreme Court Agrees To Hear Plea Over Covishield Side-Effect ConcernIndia News | Reported by Ashish Bhargava | Monday May 6, 2024 The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield. www.ndtv.comNo Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca RowIndia News | NDTV Newsdesk | Thursday May 2, 2024 The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects. www.ndtv.comAstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In IndiaIndia News | Press Trust of India | Wednesday May 3, 2023 AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer. www.ndtv.comIndian Medical Experts Support Call For Covishield Vaccine Safety ReviewIndia News | Press Trust of India | Monday February 6, 2023 A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of the Oxford/AstraZeneca's COVID-19 vaccine, administered in India as Covishield. www.ndtv.comAstraZeneca India Gets Approval To Market Drug Treating Breast CancerIndia News | Press Trust of India | Friday August 19, 2022 Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer. www.ndtv.comLancet Study On Covishield Vaccine Protection Decline Is Misquoted: ExpertsIndia News | Asian News International | Thursday December 23, 2021 The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts. www.ndtv.comNext Virus Could Be More Lethal, Warns Oxford University Covid Vaccine CreatorWorld News | Press Trust of India | Monday December 6, 2021 The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious. www.ndtv.comCOVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: ReportWorld News | Press Trust of India | Friday August 27, 2021 A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday. www.ndtv.comClotting Linked With AstraZeneca Vaccine Very Rare, Says Oxford StudyWorld News | Press Trust of India | Thursday August 12, 2021 The very rare blood clots that can be caused by the Oxford/AstraZeneca coronavirus vaccine can be aggressive and deadly but is very rare, leading scientists have concluded in the findings of the first study of its kind on Thursday. www.ndtv.comCovishield Shot Should Be Accepted In Travel Schemes: UK's Boris JohnsonIndia News | Reuters | Friday July 2, 2021 British Prime Minister Boris Johnson on Friday said he saw no reason why people who received Indian-made AstraZeneca COVID-19 vaccines should be left out of vaccine passport schemes after the European Union did not initially recognise it. www.ndtv.comNo Ban On Covishield, Request Must For Approval Process: EU Envoy To IndiaIndia News | Asian News International | Tuesday June 29, 2021 European Union (EU) Ambassador to India Ugo Astuto has clarified there is no ban in the EU on the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University. www.ndtv.comMore News »'India On Astrazeneca' - 43 Video Result(s)Israel Takes Control Of Gaza Side Of Rafah Border, Indians Hesitate To Join Student Protests In US And MoreMay 8, 202423:55Supreme Court Agrees To Hear Plea Over Covishield Side-Effect ConcernMay 6, 20241:53"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-EffectMay 5, 20244:27"Information Is Not New, No Need To Worry": Ex WHO Chief Scientist On Covishield ConcernMay 5, 20244:56"All Drugs, Vaccines Come With Some Side-Effects": Top ExpertMay 5, 20241:07"No Vaccine Is 100% Effective Or 100% Safe": Expert On Covishield ConcernMay 5, 20242:18Ex WHO Chief Scientist, Top Doctors Answer AstraZeneca Vaccine ConcernsMay 5, 202426:44Astrazeneca's Big U-Turn, Admits Rare Blood Clot RiskApr 30, 20242:21Had Detailed Conversations On UK, India Vaccine App: UK Envoy To NDTVSep 22, 20211:33"Let In Jasprit Bumrah To Humiliate Us In Oval": UK Envoy To NDTVSep 22, 20210:43"Aim Is To Get India On List Of Countries That Don't Need Quarantine": UK EnvoySep 22, 202110:24On UK Vaccine Policy Row, Government Warns Of "Reciprocal Measures"Sep 21, 20212:36Different Booster Shots The Way Forward?Jun 23, 20217:15Indian Vaccine Export Ban Makes 91 Nations Vulnerable To New Strains: WHOJun 1, 20215:07Two Shots Of Covid Vaccines Effective Against Variant Found In India: UKMay 23, 20211:13More Videos »Your search did not match any documentsA few suggestionsMake sure all words are spelled correctlyTry different keywordsTry more general keywordsCheck the NDTV Archives:https://archives.ndtv.com